Br-PBTC is a potent and α2/α4-subtype-selective positive allosteric modulator of nicotinic acetylcholine receptors (nAChRs), with EC50 values ranging from 0.1 to 0.6 μM for α2β2, α2β4, α4β2, α4β4, (α4β2)2α4, and (α4β2)2β2 nAChR subtypes; it acts via the C-terminal tail of the α subunit.